IgG4-related disease: what do we know after 20 years
IgG4-related disease is immunomediated fibroinflammatory condition, characterized by tumefective lesions in different organs with distinctive pathomorphological features and IgG4 hypersecretion in serum and tissues in the majority of patients. IgG4-RD has been established as a separate clinical in t...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
"Consilium Medicum" Publishing house
2020-06-01
|
| Series: | Терапевтический архив |
| Subjects: | |
| Online Access: | https://ter-arkhiv.ru/0040-3660/article/viewFile/34591/pdf |
| id |
doaj-289769fc36f64260b7116f1365d0c045 |
|---|---|
| record_format |
Article |
| spelling |
doaj-289769fc36f64260b7116f1365d0c0452021-01-26T09:27:26Zrus"Consilium Medicum" Publishing houseТерапевтический архив0040-36602309-53422020-06-0192510410910.26442/00403660.2020.05.00063231138IgG4-related disease: what do we know after 20 yearsE. V. Sokol0Nasonova Research Institute of RheumatologyIgG4-related disease is immunomediated fibroinflammatory condition, characterized by tumefective lesions in different organs with distinctive pathomorphological features and IgG4 hypersecretion in serum and tissues in the majority of patients. IgG4-RD has been established as a separate clinical in the early 2000s. In the review we focus on the evolution of views on ethiopathogenesis of the disease, therapeutic and diagnostic options and classification of the disease.https://ter-arkhiv.ru/0040-3660/article/viewFile/34591/pdfigg4-related diseasediagnostic criteriaclassification criteriapathogenesisсd4+ t cytotoxic cellsplasmabalstsmalignancylymphomaallergyabataceptrituximab |
| collection |
DOAJ |
| language |
Russian |
| format |
Article |
| sources |
DOAJ |
| author |
E. V. Sokol |
| spellingShingle |
E. V. Sokol IgG4-related disease: what do we know after 20 years Терапевтический архив igg4-related disease diagnostic criteria classification criteria pathogenesis сd4+ t cytotoxic cells plasmabalsts malignancy lymphoma allergy abatacept rituximab |
| author_facet |
E. V. Sokol |
| author_sort |
E. V. Sokol |
| title |
IgG4-related disease: what do we know after 20 years |
| title_short |
IgG4-related disease: what do we know after 20 years |
| title_full |
IgG4-related disease: what do we know after 20 years |
| title_fullStr |
IgG4-related disease: what do we know after 20 years |
| title_full_unstemmed |
IgG4-related disease: what do we know after 20 years |
| title_sort |
igg4-related disease: what do we know after 20 years |
| publisher |
"Consilium Medicum" Publishing house |
| series |
Терапевтический архив |
| issn |
0040-3660 2309-5342 |
| publishDate |
2020-06-01 |
| description |
IgG4-related disease is immunomediated fibroinflammatory condition, characterized by tumefective lesions in different organs with distinctive pathomorphological features and IgG4 hypersecretion in serum and tissues in the majority of patients. IgG4-RD has been established as a separate clinical in the early 2000s. In the review we focus on the evolution of views on ethiopathogenesis of the disease, therapeutic and diagnostic options and classification of the disease. |
| topic |
igg4-related disease diagnostic criteria classification criteria pathogenesis сd4+ t cytotoxic cells plasmabalsts malignancy lymphoma allergy abatacept rituximab |
| url |
https://ter-arkhiv.ru/0040-3660/article/viewFile/34591/pdf |
| work_keys_str_mv |
AT evsokol igg4relateddiseasewhatdoweknowafter20years |
| _version_ |
1724322969820332032 |